Literature DB >> 17227221

Genetic and environmental determinants of volumetric and areal BMD in multi-generational families of African ancestry: the Tobago Family Health Study.

Xiaojing Wang1, Candace M Kammerer, Victor W Wheeler, Alan L Patrick, Clareann H Bunker, Joseph M Zmuda.   

Abstract

UNLABELLED: BMD is higher and fracture risk is lower among individuals of African versus European descent, but little is known about the genetic architecture of BMD in the former group. Heritabilities of areal and volumetric BMD were moderate in our large families of African descent but differed for trabecular and cortical BMD.
INTRODUCTION: Populations of African ancestry have lower osteoporotic fracture risk and higher BMD than other ethnic groups. However, there is a paucity of information regarding the genetic and environmental influences on bone health among populations of African heritage.
MATERIALS AND METHODS: We dissected the genetic architecture of areal BMD measured by DXA at the proximal femur, lumbar spine, and whole body and volumetric BMD measured by pQCT at the distal and proximal radius and tibia in 283 women and 188 men > or =18 years of age (mean, 43 years) from eight multigenerational Afro-Caribbean families (mean family size > 50). Using quantitative genetic methods, we estimated the residual heritability and the effects of anthropometric, demographic, lifestyle, and medical variables on areal and volumetric BMD.
RESULTS: Compared with U.S. non-Hispanic blacks and whites, areal BMD at the femoral neck was highest in the Afro-Caribbean men and women at all ages. Trabecular volumetric BMD decreased linearly with increasing age, whereas cortical volumetric BMD did not decrease until age 40-49, especially in women. Anthropometric, lifestyle, and medical factors accounted for 12-32% of the variation in areal and volumetric BMD, and residual heritabilities (range, 0.23-0.52) were similar to those reported in other ethnic groups. Heritability of cortical BMD was substantially lower than that of areal or trabecular volumetric BMD, although the measured covariates accounted for a similar proportion of the total phenotypic variation.
CONCLUSIONS: Our study is the first comprehensive genetic epidemiologic analysis of volumetric BMD measured by QCT and the first analysis of these traits in extended families of African descent. Genes account for as much or more of the total variation in areal and volumetric BMD than do environmental factors, but these effects seem to differ for trabecular and cortical bone.

Entities:  

Mesh:

Year:  2007        PMID: 17227221     DOI: 10.1359/jbmr.070106

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  23 in total

1.  Genetic epidemiology and genome-wide linkage analysis of carotid artery ultrasound traits in multigenerational African ancestry families.

Authors:  Allison L Kuipers; Candace M Kammerer; Iva Miljkovic; Genevieve A Woodard; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Anne B Newman; Joseph M Zmuda
Journal:  Atherosclerosis       Date:  2013-09-11       Impact factor: 5.162

Review 2.  The genetics of bone loss: challenges and prospects.

Authors:  Braxton D Mitchell; Laura M Yerges-Armstrong
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

3.  Site-specific differences in bone mineral density in black and white premenopausal South African women.

Authors:  S Chantler; K Dickie; J H Goedecke; N S Levitt; E V Lambert; J Evans; Y Joffe; L K Micklesfield
Journal:  Osteoporos Int       Date:  2011-03-03       Impact factor: 4.507

4.  Rate of bone loss is greater in young Mexican American men than women: the San Antonio Family Osteoporosis Study.

Authors:  John R Shaffer; Candace M Kammerer; Amy S Dressen; Jan M Bruder; Richard L Bauer; Braxton D Mitchell
Journal:  Bone       Date:  2010-03-25       Impact factor: 4.398

5.  A comparison of principal component analysis and factor analysis strategies for uncovering pleiotropic factors.

Authors:  Xiaojing Wang; Candace M Kammerer; Stewart Anderson; Jiang Lu; Eleanor Feingold
Journal:  Genet Epidemiol       Date:  2009-05       Impact factor: 2.135

6.  Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design.

Authors:  Shesh N Rai; Melissa M Hudson; Elizabeth McCammon; Laura Carbone; Francis Tylavsky; Karen Smith; Harriet Surprise; John Shelso; Chin-Hon Pui; Sue Kaste
Journal:  Contemp Clin Trials       Date:  2008-05-18       Impact factor: 2.226

7.  High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.

Authors:  Laura M Yerges; Lambertus Klei; Jane A Cauley; Kathryn Roeder; Candace M Kammerer; Susan P Moffett; Kristine E Ensrud; Cara S Nestlerode; Lynn M Marshall; Andrew R Hoffman; Cora Lewis; Thomas F Lang; Elizabeth Barrett-Connor; Robert E Ferrell; Eric S Orwoll; Joseph M Zmuda
Journal:  J Bone Miner Res       Date:  2009-12       Impact factor: 6.741

8.  Correlates of bone mineral density among postmenopausal women of African Caribbean ancestry: Tobago women's health study.

Authors:  Deanna D Hill; Jane A Cauley; Clareann H Bunker; Carol E Baker; Alan L Patrick; Gloria L A Beckles; Victor W Wheeler; Joseph M Zmuda
Journal:  Bone       Date:  2008-03-20       Impact factor: 4.398

9.  Genetic influences on bone loss in the San Antonio Family Osteoporosis study.

Authors:  J R Shaffer; C M Kammerer; J M Bruder; S A Cole; T D Dyer; L Almasy; J W MacCluer; J Blangero; R L Bauer; B D Mitchell
Journal:  Osteoporos Int       Date:  2008-04-15       Impact factor: 4.507

10.  BMP7 gene polymorphisms are not associated with bone mineral density or osteoporotic fractures in postmenopausal Chinese women.

Authors:  Li-Hong Gao; Shan-Shan Li; Chong Shao; Wen-Zhen Fu; Yu-Juan Liu; Jin-Wei He; Zhen-Lin Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-06-06       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.